Somewhat Positive Press Coverage Somewhat Unlikely to Affect Integer (NYSE:ITGR) Share Price

News stories about Integer (NYSE:ITGR) have trended somewhat positive recently, Accern Sentiment reports. The research group rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Integer earned a coverage optimism score of 0.08 on Accern’s scale. Accern also gave news articles about the medical equipment provider an impact score of 43.6126891080794 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Integer (ITGR) opened at $48.40 on Wednesday. Integer has a 52-week low of $29.40 and a 52-week high of $55.20. The company has a current ratio of 2.58, a quick ratio of 1.37 and a debt-to-equity ratio of 1.95. The company has a market capitalization of $1,537.57, a P/E ratio of 76.83, a P/E/G ratio of 1.02 and a beta of 1.08.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $0.82 EPS for the quarter, beating the consensus estimate of $0.78 by $0.04. Integer had a return on equity of 11.22% and a net margin of 1.42%. The firm had revenue of $363.31 million during the quarter, compared to analysts’ expectations of $354.83 million. During the same period in the prior year, the firm posted $0.83 earnings per share. The business’s quarterly revenue was up 4.8% compared to the same quarter last year. equities analysts predict that Integer will post 2.62 EPS for the current fiscal year.

Several research firms have recently weighed in on ITGR. Northcoast Research cut Integer from a “buy” rating to a “neutral” rating in a research report on Monday, October 23rd. They noted that the move was a valuation call. TheStreet raised Integer from a “c+” rating to a “b-” rating in a research report on Wednesday, October 18th. BidaskClub raised Integer from a “buy” rating to a “strong-buy” rating in a research report on Thursday, September 28th. Royal Bank of Canada reissued a “hold” rating and set a $40.00 price target on shares of Integer in a research report on Friday, September 22nd. Finally, Zacks Investment Research raised Integer from a “sell” rating to a “buy” rating and set a $51.00 price target for the company in a research report on Wednesday, December 27th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $51.00.

In other news, VP Thomas J. Mazza sold 23,123 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $46.16, for a total value of $1,067,357.68. Following the completion of the sale, the vice president now directly owns 26,123 shares of the company’s stock, valued at $1,205,837.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director William B. Summers, Jr. sold 13,996 shares of the firm’s stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $49.07, for a total value of $686,783.72. Following the completion of the sale, the director now directly owns 46,179 shares of the company’s stock, valued at $2,266,003.53. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 100,625 shares of company stock valued at $4,694,219. Insiders own 4.80% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by BBNS and is the sole property of of BBNS. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://baseballnewssource.com/markets/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-integer-itgr-share-price/1822296.html.

About Integer

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Insider Buying and Selling by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets


Leave a Reply

 
© 2006-2018 BBNS.